• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名因大泌乳素瘤接受溴隐亭长期治疗的患者出现冲动控制障碍。

Impulse control disorder in a patient on long-term treatment with bromocriptine for a macroprolactinoma.

作者信息

Thondam Sravan Kumar, Alusi Sundus, O'Driscoll Kieran, Gilkes Catherine E, Cuthbertson Daniel J, Daousi Christina

机构信息

*Department of Endocrinology, University Hospital Aintree, Liverpool, England; and †Department of Neurology and Neuropsychiatry, and ‡Department of Neurosurgery, The Walton Centre for Neurology & Neurosurgery, Liverpool, England.

出版信息

Clin Neuropharmacol. 2013 Sep-Oct;36(5):170-2. doi: 10.1097/WNF.0b013e31829fc165.

DOI:10.1097/WNF.0b013e31829fc165
PMID:24045609
Abstract

Impulse control disorders (ICDs) constitute socially disruptive behaviors such as pathological gambling, impulsive eating, compulsive shopping, and hypersexuality. These conditions are well recognized in patients on dopamine agonist (DA) therapy for Parkinson disease. Dopamine agonists are widely used as first-line agents in the treatment of prolactinomas, but ICDs in this group of patients are relatively rare, perhaps because of lower therapeutic doses used. A review of the literature yielded only a few cases of ICDs in patients on DA treatment for prolactinomas. These symptoms are perhaps underreported because of lack of awareness among patients and health care professionals. Impulse control disorders are recognized psychiatric disorders that have significant psychological and social implications, and patients need to be counselled about this rare possibility when embarking on prolonged DA therapy. We describe a young patient with severe, socially disruptive impulsivity manifesting with pathological gambling who had been on long-term bromocriptine therapy for a macroprolactinoma.

摘要

冲动控制障碍(ICDs)构成了具有社会破坏性的行为,如病理性赌博、冲动性进食、强迫性购物和性欲亢进。在接受多巴胺激动剂(DA)治疗帕金森病的患者中,这些情况已得到充分认识。多巴胺激动剂被广泛用作治疗泌乳素瘤的一线药物,但这组患者中的冲动控制障碍相对少见,可能是因为使用的治疗剂量较低。对文献的回顾仅发现少数接受DA治疗泌乳素瘤的患者出现冲动控制障碍的病例。由于患者和医护人员缺乏认识,这些症状可能未得到充分报告。冲动控制障碍是公认的精神障碍,具有重大的心理和社会影响,在开始长期DA治疗时,需要向患者咨询这种罕见的可能性。我们描述了一名年轻患者,他患有严重的、具有社会破坏性的冲动行为,表现为病理性赌博,因巨大泌乳素瘤接受了长期溴隐亭治疗。

相似文献

1
Impulse control disorder in a patient on long-term treatment with bromocriptine for a macroprolactinoma.一名因大泌乳素瘤接受溴隐亭长期治疗的患者出现冲动控制障碍。
Clin Neuropharmacol. 2013 Sep-Oct;36(5):170-2. doi: 10.1097/WNF.0b013e31829fc165.
2
Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas.垂体腺瘤患者中与多巴胺能药物相关的冲动控制障碍
Clin Neuropharmacol. 2011 Sep-Oct;34(5):179-81. doi: 10.1097/WNF.0b013e3182281b2f.
3
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists.多巴胺激动剂治疗的性腺功能减退伴泌乳素瘤男性中的多巴-测试毒性:破坏性的性欲亢进。
Endocrine. 2017 Feb;55(2):618-624. doi: 10.1007/s12020-016-1088-1. Epub 2016 Sep 6.
4
Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.帕金森病患者中与冲动控制障碍症状相关的患病率及药理学因素
Clin Neuropharmacol. 2012 Nov-Dec;35(6):261-5. doi: 10.1097/WNF.0b013e31826e6e6d.
5
Dopamine Agonist-Induced Impulse Control Disorders in Patients With Prolactinoma: A Cross-Sectional Multicenter Study.多巴胺激动剂诱导的催乳素瘤患者冲动控制障碍:一项横断面多中心研究。
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2527-2534. doi: 10.1210/jc.2018-02202.
6
Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.手术联合多巴胺激动剂与单纯多巴胺激动剂治疗大泌乳素瘤的长期疗效:一项回顾性研究
Exp Clin Endocrinol Diabetes. 1998;106(3):211-6. doi: 10.1055/s-0029-1211978.
7
Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.高泌乳素血症患者多巴胺激动剂治疗后出现冲动控制障碍。
Rev Endocr Metab Disord. 2022 Oct;23(5):1089-1099. doi: 10.1007/s11154-022-09753-6. Epub 2022 Sep 20.
8
Long term follow-up of Parkinson's disease patients with impulse control disorders.帕金森病患者冲动控制障碍的长期随访。
Parkinsonism Relat Disord. 2010 Jun;16(5):334-7. doi: 10.1016/j.parkreldis.2010.02.006. Epub 2010 Mar 11.
9
Treating prolactinomas with dopamine agonists: always worth the gamble?使用多巴胺激动剂治疗泌乳素瘤:总是值得一试吗?
Endocrine. 2016 Feb;51(2):205-10. doi: 10.1007/s12020-015-0727-2. Epub 2015 Sep 4.
10
[Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].[帕金森病与不宁腿综合征中的多巴胺调节障碍综合征]
Geriatr Psychol Neuropsychiatr Vieil. 2011 Jun;9(2):227-35. doi: 10.1684/pnv.2011.0275.

引用本文的文献

1
Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study.多巴胺激动剂治疗的垂体腺瘤患者的冲动控制障碍:一项横断面多中心研究。
Pituitary. 2024 Apr;27(2):197-203. doi: 10.1007/s11102-024-01383-2. Epub 2024 Feb 12.
2
Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.高泌乳素血症患者多巴胺激动剂治疗后出现冲动控制障碍。
Rev Endocr Metab Disord. 2022 Oct;23(5):1089-1099. doi: 10.1007/s11154-022-09753-6. Epub 2022 Sep 20.
3
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study.
在接受多巴胺激动剂治疗的内分泌疾病患者中,冲动控制障碍症状的患病率增加:一项横断面研究。
J Endocrinol Invest. 2021 Aug;44(8):1699-1706. doi: 10.1007/s40618-020-01478-0. Epub 2020 Dec 12.
4
Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609.鉴定无功能垂体腺瘤的驱动基因和关键通路可预测 STO-609 的治疗效果。
PLoS One. 2020 Oct 29;15(10):e0240230. doi: 10.1371/journal.pone.0240230. eCollection 2020.
5
Impulse Control Behaviors in Parkinson's Disease: Drugs or Disease? Contribution From Imaging Studies.帕金森病中的冲动控制行为:药物还是疾病?影像学研究的贡献
Front Neurol. 2018 Oct 25;9:893. doi: 10.3389/fneur.2018.00893. eCollection 2018.
6
Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist.多巴胺能疗法的神经精神和代谢方面:内分泌学家和精神科医生的观点。
Endocr Connect. 2018 Feb;7(2):R88-R94. doi: 10.1530/EC-18-0030. Epub 2018 Jan 29.
7
Dopamine Agonists and Impulse Control Disorders: A Complex Association.多巴胺激动剂与冲动控制障碍:复杂的关联。
Drug Saf. 2018 Jan;41(1):19-75. doi: 10.1007/s40264-017-0590-6.
8
Treating prolactinomas with dopamine agonists: always worth the gamble?使用多巴胺激动剂治疗泌乳素瘤:总是值得一试吗?
Endocrine. 2016 Feb;51(2):205-10. doi: 10.1007/s12020-015-0727-2. Epub 2015 Sep 4.
9
Gambling disorder during dopamine replacement treatment in Parkinson's disease: a comprehensive review.帕金森病多巴胺替代治疗期间的赌博障碍:一项综合综述。
Biomed Res Int. 2014;2014:728038. doi: 10.1155/2014/728038. Epub 2014 Jul 8.